Palomid 529, a novel small-molecule drug, is a TORC1/TORC2 inhibitor that reduces tumor growth, tumor angiogenesis, and vascular permeability

Qi Xue, Benjamin Hopkins, Carole Perruzzi, Durga Udayakumar, David Sherris, Laura E. Benjamin

Research output: Contribution to journal › Article › peer-review

97 Scopus citations

Fingerprint

Dive into the research topics of 'Palomid 529, a novel small-molecule drug, is a TORC1/TORC2 inhibitor that reduces tumor growth, tumor angiogenesis, and vascular permeability'. Together they form a unique fingerprint.

Medicine & Life Sciences